Stage III Renal Cell Cancer AJCC v7

specific

Stage II includes: T2, N0, M0. T2: Lesions have been divided into T2a and T2b. T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney. T2b is defined as tumor greater than 10 cm, limited to the kidney. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)

80

Centers

67

Active Trials

Cancer Funding

Top Centers for Stage III Renal Cell Cancer AJCC v7(80)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.3
2
NCI Comprehensive
High-Volume Research Center
72.3
3
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
High-Volume Research Center
72.3
4
NCI Comprehensive
Active Research Program
54.3
5
NCI Comprehensive
Active Research Program
54.3
6
NCI Comprehensive
Active Research Program
54.3
7
NCI Comprehensive
Active Research Program
54.3
8
NCI Comprehensive
Active Research Program
54.3
9
NCI Comprehensive
Active Research Program
54.3
10
NCI Comprehensive
Active Research Program
54.3
11
NCI Comprehensive
Active Research Program
54.3
12
NCI Comprehensive
Active Research Program
54.3
13
NCI Comprehensive
Active Research Program
54.3
14
NCI Comprehensive
Active Research Program
54.3
15
NCI Comprehensive
Active Research Program
54.3
16
NCI Comprehensive
Active Research Program
54.3
17
NCI Comprehensive
Active Research Program
54.3
18
NCI Comprehensive
Active Research Program
54.3
19
NCI Comprehensive
Active Research Program
54.3
20
NCI Comprehensive
Active Research Program
54.3
21
NCI Comprehensive
Active Research Program
54.3
22
NCI Comprehensive
Active Research Program
54.3
23
NCI Comprehensive
Active Research Program
54.3
24
NCI Comprehensive
Active Research Program
54.3
25
NCI Comprehensive
Active Research Program
54.3
26
NCI Comprehensive
Active Research Program
54.3
27
NCI Comprehensive
Active Research Program
54.3
28
NCI Comprehensive
Active Research Program
54.3
29
NCI Clinical
Active Research Program
54.3
30
NCI Comprehensive
Active Research Program
54.3
31
NCI Comprehensive
Active Research Program
54.3
32
NCI Comprehensive
Active Research Program
54.3
33
NCI Comprehensive
Active Research Program
54.3
34
NCI Comprehensive
Active Research Program
54.3
35
NCI Clinical
Active Research Program
54.3
36
NCI Comprehensive
Active Research Program
54.3
37
Active Research Program
54.3
38
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
54.3
39
NCI Comprehensive
Active Research Program
54.3
40
Active Research Program
54.3
41
Active Research Program
54.3
42
NCI Comprehensive
Active Research Program
54.3
43
NCI Clinical
Active Research Program
54.3
44
NCI Comprehensive
Active Research Program
54.3
45
NCI Comprehensive
Active Research Program
54.3
46
NCI Comprehensive
Active Research Program
54.3
47
Active Research Program
54.3
48
NCI Clinical
Active Research Program
54.3
49
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
54.3
50
Active Research Program
54.3
51
NCI Comprehensive
Active Research Program
54.3
5254.3
53
Active Research Program
54.3
54
Active Research Program
54.3
55
Active Research Program
54.3
56
Active Research Program
54.3
57
Active Research Program
54.3
58
Active Research Program
54.3
59
Active Research Program
54.3
60
Active Research Program
54.3
61
Active Research Program
54.3
62
Active Research Program
54.3
63
Active Research Program
54.3
64
Active Research Program
54.3
65
NCI Comprehensive
32.6
66
NCI Comprehensive
32.6
67
NCI Comprehensive
32.6
68
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
32.6
6932.6
70
NCI Comprehensive
32.6
71
NCI Comprehensive
32.6
7232.6
7332.6
7432.6
75
NCI Basic_laboratory
32.6
7632.6
7732.6
7832.6
79
BC CancerVancouver, BC
32.6
8032.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →